Skip to main content

Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus.

Publication ,  Journal Article
Buckley, MA; Woods, NT; Tyrer, JP; Mendoza-Fandiño, G; Lawrenson, K; Hazelett, DJ; Najafabadi, HS; Gjyshi, A; Carvalho, RS; Lyra, PC; Shen, HC ...
Published in: Cancer Res
February 1, 2019

Genome-wide association studies have identified 40 ovarian cancer risk loci. However, the mechanisms underlying these associations remain elusive. In this study, we conducted a two-pronged approach to identify candidate causal SNPs and assess underlying biological mechanisms at chromosome 9p22.2, the first and most statistically significant associated locus for ovarian cancer susceptibility. Three transcriptional regulatory elements with allele-specific effects and a scaffold/matrix attachment region were characterized and, through physical DNA interactions, BNC2 was established as the most likely target gene. We determined the consensus binding sequence for BNC2 in vitro, verified its enrichment in BNC2 ChIP-seq regions, and validated a set of its downstream target genes. Fine-mapping by dense regional genotyping in over 15,000 ovarian cancer cases and 30,000 controls identified SNPs in the scaffold/matrix attachment region as among the most likely causal variants. This study reveals a comprehensive regulatory landscape at 9p22.2 and proposes a likely mechanism of susceptibility to ovarian cancer. SIGNIFICANCE: Mapping the 9p22.2 ovarian cancer risk locus identifies BNC2 as an ovarian cancer risk gene.See related commentary by Choi and Brown, p. 439.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Res

DOI

EISSN

1538-7445

Publication Date

February 1, 2019

Volume

79

Issue

3

Start / End Page

467 / 481

Location

United States

Related Subject Headings

  • Polymorphism, Single Nucleotide
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Linkage Disequilibrium
  • Humans
  • HEK293 Cells
  • Genome-Wide Association Study
  • Genetic Predisposition to Disease
  • Female
  • DNA-Binding Proteins
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Buckley, M. A., Woods, N. T., Tyrer, J. P., Mendoza-Fandiño, G., Lawrenson, K., Hazelett, D. J., … Ovarian Cancer Association Consortium, . (2019). Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus. Cancer Res, 79(3), 467–481. https://doi.org/10.1158/0008-5472.CAN-17-3864
Buckley, Melissa A., Nicholas T. Woods, Jonathan P. Tyrer, Gustavo Mendoza-Fandiño, Kate Lawrenson, Dennis J. Hazelett, Hamed S. Najafabadi, et al. “Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus.Cancer Res 79, no. 3 (February 1, 2019): 467–81. https://doi.org/10.1158/0008-5472.CAN-17-3864.
Buckley MA, Woods NT, Tyrer JP, Mendoza-Fandiño G, Lawrenson K, Hazelett DJ, et al. Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus. Cancer Res. 2019 Feb 1;79(3):467–81.
Buckley, Melissa A., et al. “Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus.Cancer Res, vol. 79, no. 3, Feb. 2019, pp. 467–81. Pubmed, doi:10.1158/0008-5472.CAN-17-3864.
Buckley MA, Woods NT, Tyrer JP, Mendoza-Fandiño G, Lawrenson K, Hazelett DJ, Najafabadi HS, Gjyshi A, Carvalho RS, Lyra PC, Coetzee SG, Shen HC, Yang AW, Earp MA, Yoder SJ, Risch H, Chenevix-Trench G, Ramus SJ, Phelan CM, Coetzee GA, Noushmehr H, Hughes TR, Sellers TA, Goode EL, Pharoah PD, Gayther SA, Monteiro ANA, Ovarian Cancer Association Consortium. Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus. Cancer Res. 2019 Feb 1;79(3):467–481.

Published In

Cancer Res

DOI

EISSN

1538-7445

Publication Date

February 1, 2019

Volume

79

Issue

3

Start / End Page

467 / 481

Location

United States

Related Subject Headings

  • Polymorphism, Single Nucleotide
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Linkage Disequilibrium
  • Humans
  • HEK293 Cells
  • Genome-Wide Association Study
  • Genetic Predisposition to Disease
  • Female
  • DNA-Binding Proteins